SCHEMBL1838293

SCHEMBL1838293

CCCC[C@H](N)C(=O)OC(C)C

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC15A1 P46059 1/20 0.50
DPP7 Q9UHL4 7/20 0.46
LMNA P02545 2/20 0.46
SLC1A2 P43004 2/20 0.43
SLC1A1 P43005 2/20 0.43
SLC1A3 P43003 1/20 0.43
DPP8 Q6V1X1 6/20 0.42
DPP4 P27487 5/20 0.42
DPP9 Q86TI2 5/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
METAP1 P53582 1/20 0.41
TP53 P04637 1/20 0.38
GRIK1 P39086 2/20 0.38
GRIK2 Q13002 2/20 0.38
FAAH O00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1838292 1.00 SLC15A1 (0.50) SLC15A1DPP7LMNASLC1A2SLC1A1
SCHEMBL8413576 0.92 LMNA (0.52) SLC15A1DPP7LMNASLC1A2SLC1A1
SCHEMBL15075211 0.88 SLC1A2 (0.39) SLC15A1DPP7LMNASLC1A2SLC1A1
SCHEMBL10205198 0.88 SLC1A2 (0.39) SLC15A1DPP7LMNASLC1A2SLC1A1
SCHEMBL28346998 0.86 SLC15A1 (0.49) SLC15A1DPP7SLC1A2SLC1A1SLC1A3
SCHEMBL31015685 0.86 FAAH (0.51) SLC15A1DPP7SLC1A2SLC1A1SLC1A3
SCHEMBL8778638 0.84 GSR (0.45) SLC15A1DPP7LMNADPP8DPP4
SCHEMBL28024261 0.84 TSHR (0.34) SLC15A1DPP7LMNASLC1A2SLC1A1
SCHEMBL8778639 0.84 GSR (0.45) SLC15A1DPP7LMNADPP8DPP4
SCHEMBL6437091 0.82 GSR (0.53) DPP7DPP8DPP4DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957205-B2 Cycloalkane carboxamide derivatives and production process of same SEIKAGAKU CORPORATION (JP) 2015-02-17 US disclosed
US-8829209-B2 Cycloalkylcarbonylamino acid ester derivative and process for producing the same SEIKAGAKU CORPORATION (JP) 2014-09-09 US disclosed
EP-2036920-B1 CYCLOALKYLCARBONYLAMINO ACID ESTER DERIVATIVE AND PROCESS FOR PRODUCING THE SAME SEIKAGAKU KOGYO CO LTD (JP) 2011-05-18 EP disclosed
US-20090156805-A1 Cycloalkane Carboxamide Derivatives and Production Process of Same SEIKAGAKU CORPORATION (JP) 2009-06-18 US disclosed
US-20090137799-A1 Cycloalkylcarbonylamino Acid Ester Derivative and Process for Producing The Same SEIKAGAKU CORPORATION (JP) 2009-05-28 US disclosed
EP-2036920-A1 CYCLOALKYLCARBONYLAMINO ACID ESTER DERIVATIVE AND PROCESS FOR PRODUCING THE SAME SEIKAGAKU CORPORATION (JP) 2009-03-18 EP disclosed
EP-1972615-A1 CYCLOALKANECARBOXAMIDE DERIVATIVE AND METHOD FOR PRODUCING SAME SEIKAGAKU CORPORATION (JP) 2008-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156805-A1 Cycloalkane Carboxamide Derivatives and Production Process of Same CTSK, CTSS, CTSB SLC15A1 2076/4885DPP7 277/4885LMNA 3170/4885
US-20090137799-A1 Cycloalkylcarbonylamino Acid Ester Derivative and Process for Producing The Same CTSK, CTSS, CTSE SLC15A1 1651/4885DPP7 249/4885LMNA 2238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.